clinical trials are unusual in that enrollment of subjects is a continual process staggered in time if a treatment can be proven to be clearly beneficial or harmful compared to the concurrent control or to be obviously futile based on a pre defined analysis of an incomplete data set while the study is on going the investigators may stop the study early the design of many clinical trials includes some strategy for early stopping if an interim analysis reveals large differences between treatment groups or shows obvious futility such that there is no chance that continuing to the end would show a clinically meaningful effect in addition to saving time and resources such a design feature can reduce study participants exposure to an inferior or useless treatment however when repeated significance testing on accumulating data is done some adjustment of the usual hypothesis testing procedure must be made to maintain an overall significance level the methods described by pocock and o brien fleming among others are popular implementations of group sequential testing for clinical trials sometimes interim analyses are equally spaced in terms of calendar time or the information available from the data but this assumption can be relaxed to